Discover
NSPR
InspireMD, Inc.
0.68
7 x 0.90
7 x 0.81
bid
ask
-
0.02
2.51%
7 @ 04:00 PM
0.69 +0.01 (1.83%)
| Ytd | -61.66% | |
| 1y | -69.39% |
0.67
day range
0.72
0.63
52 week range
2.93
| Open | 0.72 | Prev Close | 0.70 | Low | 0.67 | High | 0.72 | Mkt Cap | 31.97M |
| Vol | 63.68K | Avg Vol | 316.31K | EPS | -0.70 | P/E | N/A | Forward P/E | -4.15 |
| Beta | 0.93 | Short Ratio | 2.26 | Inst. Own | 40.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 0.97 | 200-d Avg | 1.66 | 1yr Est | 4.75 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-12 | 2024-09 | -0.2 | -0.16 | 0.04 | 20.00% |
| 2024-08-06 | 2024-06 | -0.19 | -0.22 | -0.03 | -15.79% |
| 2024-05-14 | 2024-03 | -0.15 | -0.21 | -0.06 | -40.00% |
| 2024-03-06 | 2023-12 | -0.2 | -0.16 | 0.04 | 20.00% |
| 2023-11-06 | 2023-09 | -0.17 | -0.15 | 0.02 | 11.76% |
| 2023-08-08 | 2023-06 | -0.17 | -0.24 | -0.07 | -41.18% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-12-11 | Lake Street | Upgrade | Buy | |
| 2023-11-02 | Piper Sandler | Upgrade | Overweight | Overweight |
| 2023-06-12 | Piper Sandler | Upgrade | Overweight | |
| 2023-05-17 | National Alliance Securities | Upgrade | Buy | |
| 2023-03-31 | Alliance Global Partners | Upgrade | Buy |
Profile
InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-01-22 | ARNOLD KATHRYN | Director | 215.04K | Stock Award(Grant) |
| 2024-06-23 | BERMAN MICHAEL | Director | 0.00 | Conversion of Exercise of derivative security |
| 2024-01-22 | GLEASON SHANE THOMAS | Officer | 514.37K | Stock Award(Grant) |
| 2024-05-27 | KESTER THOMAS J | Director | 326.65K | Conversion of Exercise of derivative security |
| 2024-05-27 | ROUBIN GARY S | Director | 501.79K | Conversion of Exercise of derivative security |
| 2024-01-22 | SHORE CRAIG | Chief Financial Officer | 879.84K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Rosalind Advisors, Inc. | 2.51M | 7.42M | 9.64% |
| 2024-09-29 | Nantahala Capital Management, LLC | 2.21M | 6.52M | 8.47% |
| 2024-09-29 | Orbimed Advisors LLC. | 2.13M | 6.29M | 8.18% |
| 2024-09-29 | Marshall Wace LLP | 1.86M | 5.49M | 7.13% |
| 2024-09-29 | Soleus Capital Management, L.P. | 1.38M | 4.07M | 5.28% |
| 2024-09-29 | Velan Capital Investment Management LP | 904.03K | 2.67M | 3.47% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 18.24K | 53.82K | 0.07% |
Split
| Split | Date |
|---|---|
| 1 : 15 | 2021-04-27 |
| 1 : 50 | 2019-04-01 |
| 1 : 35 | 2018-02-08 |
| 1 : 25 | 2016-10-10 |
| 1 : 10 | 2015-10-01 |
| 0.25 : 1 | 2012-12-21 |